Literature DB >> 9736404

Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.

T Sano1, T Oyama, K Kashiwabara, T Fukuda, T Nakajima.   

Abstract

Both p16 and retinoblastoma (Rb) proteins are important tumor suppressors that regulate the cell cycle. The status of both proteins in invasive cervical cancer and cervical intraepithelial neoplasia (CIN) has not yet been examined. The aim of this study was to investigate the expression of p16 and Rb proteins by immunohistochemistry using 98 formalin-fixed and paraffin-embedded samples of various cervical neoplastic lesions. Strong immunoreactivity for the p16 protein was observed in both the nuclei and cytoplasm of all CIN and invasive cancer cases except several low-grade CIN lesions. Expression of Rb protein was also demonstrated in the scattered nuclei of neoplastic and normal cells in all cases investigated. The results suggest that the deletion or mutational inactivity of both p16 and Rb proteins may be a rare event in cervical carcinogenesis. Moreover, overexpression of the p16 protein may be a useful diagnostic marker for cervical neoplastic lesions on routine laboratory screening.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736404     DOI: 10.1111/j.1440-1827.1998.tb03954.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  22 in total

1.  Epidemiological aspects of cancer screening in Germany.

Authors:  Nikolaus Becker
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

2.  p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.

Authors:  Giovanni Negri; Fabio Vittadello; Fabio Romano; Armin Kasal; Francesco Rivasi; Salvatore Girlando; Christine Mian; Eduard Egarter-Vigl
Journal:  Virchows Arch       Date:  2004-10-09       Impact factor: 4.064

3.  Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.

Authors:  Zhongchuan Will Chen; Ilan Weinreb; Suzanne Kamel-Reid; Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2012-07-17

Review 4.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

5.  Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma.

Authors:  Po Zhao; Ying-Chuan Hu; Ian C Talbot
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

6.  Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions.

Authors:  T Sano; T Oyama; K Kashiwabara; T Fukuda; T Nakajima
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

7.  p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

Authors:  N Murphy; M Ring; A G Killalea; V Uhlmann; M O'Donovan; F Mulcahy; M Turner; E McGuinness; M Griffin; C Martin; O Sheils; J J O'Leary
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

8.  Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer.

Authors:  Takuma Fujii; Miyuki Saito; Takashi Iwata; Nobumaru Hirao; Hiroshi Nishio; Akiko Ohno; Katsumi Tsukazaki; Makio Mukai; Kaori Kameyama; Daisuke Aoki
Journal:  Virchows Arch       Date:  2008-10-21       Impact factor: 4.064

9.  Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining.

Authors:  G Negri; G Moretto; E Menia; F Vittadello; A Kasal; C Mian; E Egarter-Vigl
Journal:  J Clin Pathol       Date:  2006-02-07       Impact factor: 3.411

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.